Search

AbbVie's rapidly expanding Humira successor, SKYRIZI, is already achieving impressive sales growth. This IL-23 inhibitor is set to capture an even greater portion of Humira's diminishing market share with its [...]

Dublin: The 'Ulcerative Colitis Patient Pool Analysis, Market Size and Market Forecast APAC - 2034' report has been added to ResearchAndMarkets.com's offering. A new analytical report presents a thorough perspective [...]

Abivax provides 2024 strategic outlook and lays out key milestones over next 12 months Induction data read-out expected Q1 2025 from the pivotal Phase 3 ABTECT program evaluating obefazimod in [...]

Expect to announce data from SZN-043 Phase 1a clinical trial in patients with chronic liver disease and in healthy volunteers in Q1 2024 Expect to announce data from SZN-1326 Phase [...]

New York: The ulcerative colitis market is expected to grow positively by 2032, with key companies like Arena, Pfizer, Abivax, InDex, AbbVie, Boehringer Ingelheim, Janssen Pharmaceuticals, Landos Biopharma, NImmune, Merck, [...]

2024 FEB 18 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Devices & Surgical Technology Week -- Current study results on ulcerative colitis have been published. According to [...]

Dublin: Research and Markets has issued the following news release: The 'Ulcerative Colitis Global Market Report 2023' report has been added to ResearchAndMarkets.com's offering. The global ulcerative colitis market is [...]

Dublin: Research and Markets has issued the following news release: The global ulcerative colitis market is set to experience robust expansion, with a projected growth from $6.35 billion in 2022 [...]

The https://www.researchandmarkets.com/report/ulcerative-colitis?utm_source=CI&utm_medium=PressRelease&utm_code=2d3v3n&utm_campaign=1889655+-+Rising+Healthcare+Expenditures+Propel+Ulcerative+Colitis+Market+-+Expected+to+Surpass+%248.86+Billion+by+2027&utm_exec=jamu273prd report has been added toResearchAndMarkets.com's offering. DUBLIN, Sept. 18, 2023 /PRNewswire/ -- The global ulcerative colitis market is set to experience robust expansion, with a projected growth from [...]

(GlobeNewswire) - The global anti-inflammatory drugs market size reached USD 111.42 Billion in 2021 and is expected to register a revenue CAGR of 9.3% during the forecast period, according to [...]

M2 PRESSWIRE-September 11, 2023-: Ulcerative Colitis Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | AbbVie, Boehringer, Eli Lilly and Company, Janssen, Mesoblast, Pfizer [...]

DUBLIN: The 'Ulcerative Colitis (UC) Epidemiology Forecast to 2032' report has been added to ResearchAndMarkets.com's offering. The 7 major markets (7MM) are projected to experience a rise from around 3,012,740 [...]

Burlingame, July 28, 2023 (GLOBE NEWSWIRE) -- T he global Humira biosimilar Market is approximated to be $772.1 million in 2023 , and it is projected to reach $ 3,871.4 [...]

M2 PRESSWIRE-June 21, 2023-: Ulcerative Colitis Market to Register Sustainable Growth During the Forecast Period (2023-2032) - DelveInsight | InDex, EA Pharma, Theravance, Janssen, Lycera, LG Chem, Iltoo Pharma, Immunic, [...]

Acquisition delivers industry-leading research capability, and strengthens pipeline with a novel candidate for ulcerative colitis, Crohn's disease and other autoimmune conditions RAHWAY, N.J. -- Merck (NYSE: MRK), known as MSD [...]

LONDON: Brandessence Market Research and Consulting Private Limited has issued the following news release: In this world of adulterated food products and rapidly changing lifestyle trends, digestive disorders have become [...]

LONDON, May 18, 2023 /PRNewswire/ -- In this world of adulterated food products and rapidly changing lifestyle trends, digestive disorders have become highly prevalent. Many people deal with digestive illnesses, [...]

New York: Market Research Future has issued the following press release: Inflammatory Bowel Disease Treatment Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), 'Inflammatory Bowel [...]

The ulcerative colitis (UC) market across the eight major markets (8MM) is forecast to grow at a compound annual growth rate (CAGR) of 2.8% from $7.2 bn in 2021 to $9.6 bn in 2031, driven by the potential introduction of 11 promising late-stage pipeline products and an increase in the prevalent patient population, according to GlobalData, a leading data and analytics company. GlobalData's report, 'Ulcerative Colitis (UC) Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2031,' reveals that 11 pipeline therapies - Roivant Sciences' RVT-3101, AbbVie's Skyrizi (risankizumab), Eli Lilly's mirikizumab, Janssen's Tremfya, Boehringer Ingelheim's Spesolimab, Reistone Biopharma's ivarmacitinib, Pfizer's ritlecitinib and etrasimod, NImmune Biopharma's omilancor, Abivax's obefazimod and InDex Pharma's cobitolimod - will enter the UC market. Agents with novel routes of administration are anticipated to differentiate such therapies in the UC market. Due to the new rectal route of administration cobitolimod offers, it is anticipated to make an impact in the UC market. Cobitolimod is forecast to launch in the US in 2028 but is expected to face competition from agents such as Janus kinase (JAK) inhibitors ivarmacitinib, ritlecitinib which are also entering the US market in 2028. Although the UC market is projected to grow in the 8MM over the forecast period, limited growth is anticipated in Japan. Mirikizumab and Skyrizi are the only late-stage pipeline products set to launch in Japan. The countries covered in the 8MM ate the US, France, Germany, Italy, Spain, the UK, Japan, and Canada. Original source: Global Data, website: http://www.energy.globaldata.com, Copyright Global Data 2023., market; cobitolimod; enzyme inhibitors; etrasimod; gastrointestinal drugs; ivarmacitinib; mirikizumab; monoclonal antibodies; obefazimod; omilancor; risankizumab; ritlecitinib; Skyrizi; Spesolimab; therapeutic antibodies; Tremfya; AbbVie; Abivax; Boehringer Ingelheim; Eli Lilly; InDex Pharma; Janssen; NImmune [...]

M2 PRESSWIRE-January 11, 2023-: Ulcerative Colitis Market Report 2032: Market analysis, Treatment, Drugs and Medicine, Key Companies and Competitive Landscape by DelveInsight (C)1994-2023 M2 COMMUNICATIONS RDATE:10012023 DelveInsight's Ulcerative Colitis Market [...]

LA JOLLA, Calif. -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that Biocon Limited, in [...]

M2 PRESSWIRE-November 22, 2022-: Ulcerative Colitis Market to Observe Stupendous Growth at a CAGR of 9.4% by 2032 - Estimates DelveInsight | Key Companies - AbbVie, Boehringer Ingelheim, Arena Pharma, [...]

DUBLIN: Research and Markets has issued the following news release: The 'Ulcerative Colitis Market Forecast - Epidemiology & Pipeline Analysis 2022-2027' report has been added to ResearchAndMarkets.com's offering. The ulcerative [...]

DUBLIN, Sept. 2, 2022 /PRNewswire/ -- The https://www.researchandmarkets.com/reports/5642942/ulcerative-colitis-market-forecast-epidemiology?utm_source=CI&utm_medium=PressRelease&utm_code=g3d5vq&utm_campaign=1743668+-+8+MM+Ulcerative+Colitis+Market+Forecasts%2c+Epidemiology+%26+Pipeline+Analysis+2022-2027%3a+Novel+Emerging+Drugs+will+Shift+the+Inflammatory+Bowel+Disease+(IBD)+Treatment+Paradigm&utm_exec=chdo54prd report has been added toResearchAndMarkets.com's offering. The ulcerative colitis epidemiology provides insights into the historical and current patient pools and forecasted trends [...]

DUBLIN, Sept. 1, 2022 /PRNewswire/ -- The https://www.researchandmarkets.com/reports/5559807/microbiome-global-market-report-2022-type?utm_source=CI&utm_medium=PressRelease&utm_code=b3jc8h&utm_campaign=1743623+-+Microbiome+Global+Market+to+Reach+%24940+Million+by+2025+at+a+CAGR+of+25%25&utm_exec=como322prd report has been added toResearchAndMarkets.com's offering. The global microbiome market is expected to grow from $0.27 billion in 2020 to $0.37 billion [...]

DUBLIN: Research and Markets has issued the following news release: The 'Ulcerative Colitis Market Forecast - Epidemiology & Pipeline Analysis 2022-2027' report has been added to ResearchAndMarkets.com's offering. The ulcerative [...]

DUBLIN -- The 'Ulcerative Colitis Market Forecast - Epidemiology & Pipeline Analysis 2022-2027' report has been added to ResearchAndMarkets.com's offering. The ulcerative colitis epidemiology provides insights into the historical and [...]

M2 PRESSWIRE-August 23, 2022-: Ulcerative Colitis Market Forecasts, Epidemiology & Pipeline Analysis 2022-2027: Focus on 8 Major Markets - United States, France, Germany, Italy, Spain, United Kingdom, China, and Japan [...]

New York: ReportLinker has issued the following news release: Reportlinker.com announces the release of the report 'Ulcerative Colitis Market Forecast - Epidemiology & Pipeline Analysis 2022-2027' - https://www.reportlinker.com/p06313605/?utm_source=GNW The ulcerative [...]

SOUTH SAN FRANCISCO, May 18, 2022 (GLOBE NEWSWIRE via COMTEX) -- EQNX::TICKER_START (NASDAQ:SRZN), EQNX::TICKER_END -- First part of three-part Phase 1/1b trial starts in healthy volunteers Surrozen, Inc. ('Surrozen' or [...]

(GlobeNewswire) - According to Coherent Market Insights, the China ulcerative colitis market is estimated to be valued at US$ 185 million in 2021 and is expected to exhibit a CAGR [...]

SEATTLE, Jan 19, 2022 (GLOBE NEWSWIRE via COMTEX) -- According to Coherent Market Insights, the China ulcerative colitis market is estimated to be valued at US$ 185 million in 2021 [...]

DUBLIN: Research and Markets has issued the following news release: The 'Global Inflammatory Bowel Disease (IBD) Market - Analysis By Disease Indication (Crohn's Disease, Ulcerative Colitis), Drug Class, Distribution Channel, [...]

DUBLIN, Dec. 15, 2021 /PRNewswire/ -- The 'Global Inflammatory Bowel Disease (IBD) Market - Analysis By Disease Indication (Crohn's Disease, Ulcerative Colitis), Drug Class, Distribution Channel, By Region, By Country [...]

Dublin, Nov 08, 2021 (GLOBE NEWSWIRE via COMTEX) -- The 'Inflammatory Bowel Disease Treatment Market Size, Share & Trends Analysis Report By Type (Crohn's Disease, Ulcerative Colitis), By Drug Class, [...]

SEATTLE,; According to Coherent Market Insights, the global inflammatory bowel disease market is estimated to be valued at US$ 1,821.8 million in 2021 and is expected to exhibit a CAGR [...]

DUBLIN: Research and Markets has issued the following news release: The 'Disease Analysis: Ulcerative Colitis' report has been added to ResearchAndMarkets.com's offering. UC typically presents with bloody diarrhea, which may [...]

DUBLIN, July 12, 2021 /PRNewswire/ -- The 'Disease Analysis: Ulcerative Colitis' report has been added toResearchAndMarkets.com's offering. UC typically presents with bloody diarrhea, which may manifest alongside mucus, rectal urgency, [...]

M2 PRESSWIRE-July 7, 2021-: Ulcerative Colitis Market Size is expected to grow at a CAGR of 9.5% in 7MM for the study period (2018-2030) by DelveInsight| Boehringer Ingelheim, AbbVie, Arena [...]

SOUTH SAN FRANCISCO, May 13, 2021 (GLOBE NEWSWIRE via COMTEX) -- Enrollment ongoing in each of oral AMT-101's four Phase 2 trials On track to announce oral AMT-101 top-line data [...]

(GlobeNewswire) - The 'Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2029' report has been added to ResearchAndMarkets.com's offering. The current UC market is overcrowded with cheap generic [...]

(GlobeNewswire) - The 'Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2029' report has been added to ResearchAndMarkets.com's offering. The current UC market is overcrowded with cheap generic [...]

Dublin, Jan 12, 2021 (GLOBE NEWSWIRE via COMTEX) -- The 'Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2029' report has been added to ResearchAndMarkets.com's offering. The current [...]

SOUTH SAN FRANCISCO, Calif., Nov 12, 2020 (GLOBE NEWSWIRE via COMTEX) -- - Company on track with comprehensive AMT-101 Phase 2 clinical program across multiple indications, including inflammatory bowel diseases [...]

M2 PRESSWIRE-October 28, 2020-: Ulcerative Colitis Epidemiology Forecast to 2029 (C)1994-2020 M2 COMMUNICATIONS RDATE:28102020 The 'Ulcerative Colitis - Epidemiology Forecast to 2029' report has been added to ResearchAndMarkets.com's offering. Ulcerative [...]

New Delhi, Aug. 3 -- Market Overview: According to Market Research, Future (MRFR), the Inflammatory Bowel Disease Treatment Market is expected to record a 2.5% CAGR during the prediction period. [...]

M2 PRESSWIRE-July 15, 2020-: Ulcerative Colitis Market Size Is Projected to Grow at a CAGR of 7% By 2022 | COVID-19 Impact, Future Dynamics and Global industry Insights (C)1994-2020 M2 [...]

DUBLIN, May 12, 2020 /PRNewswire/ -- The 'Global Ulcerative Colitis Market and Competitive Landscape - 2020' report has been added to ResearchAndMarkets.com's offering. This research report provides comprehensive insights into [...]

NEW YORK, June 3, 2019 /PRNewswire/ -- Summary Read the full report: https://www.reportlinker.com/p05779520/?utm_source=PRN Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) characterized by long-lasting inflammation and ulcers (sores) in [...]

New Delhi, April 22 -- Global Inflammatory Bowel Disease (IBD) Treatment Market: Snapshot Inflammatory Bowel disease is a group of gastrointestinal inflammatory diseases which mainly comprises of Ulcerative colitis and [...]